Format
Sort by
Items per page

Send to

Choose Destination

Best matches for San Millán JL[au]:

Unified criteria for ultrasonographic diagnosis of ADPKD. Pei Y et al. J Am Soc Nephrol. (2009)

Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones. Murri M et al. Metabolism. (2018)

Microcins. Moreno F et al. Biotechnology. (1995)

Search results

Items: 1 to 50 of 97

1.

Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.

Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Luque-Ramírez M, Escobar-Morreale HF.

Metabolism. 2018 Sep;86:49-60. doi: 10.1016/j.metabol.2018.01.011. Epub 2018 Feb 2.

PMID:
29410349
2.

Serum Bioavailable Vitamin D Concentrations and Bone Mineral Density in Women After Obesity Surgery.

Botella-Carretero JI, Lafuente C, Montes-Nieto R, Balsa J, Vega-Piñero B, Garcia-Moreno F, Peromingo R, Galindo J, San-Millan JL, Escobar-Morreale H.

Obes Surg. 2016 Nov;26(11):2732-2737.

PMID:
27116295
3.

Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.

Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1835-44. doi: 10.1210/jc.2013-2218. Epub 2013 Sep 13.

PMID:
24037889
4.

The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.

Martínez-García MA, San-Millán JL, Escobar-Morreale HF.

Gene. 2012 Apr 10;497(1):38-44. doi: 10.1016/j.gene.2012.01.047. Epub 2012 Jan 28.

PMID:
22306327
5.

Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in research.

Insenser M, Martínez-García M, Nieto RM, San-Millán JL, Escobar-Morreale HF.

Proteomics Clin Appl. 2010 Sep;4(8-9):739-44.

PMID:
21174910
6.

Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation.

Insenser M, Martínez-García MA, Montes R, San-Millán JL, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2010 Aug;95(8):3863-70. doi: 10.1210/jc.2010-0220. Epub 2010 May 19.

PMID:
20484478
7.

Vitamin D receptor polymorphisms in secondary hyperparathyroidism after Scopinaro's biliopancreatic diversion.

Balsa JA, Iglesias B, Peromingo R, Conde S, Vazquez C, San-Millan JL, Botella-Carretero JI.

Obes Surg. 2010 Oct;20(10):1415-21. doi: 10.1007/s11695-010-0144-9.

PMID:
20383754
8.

The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence.

San-Millán JL, Escobar-Morreale HF.

Clin Endocrinol (Oxf). 2010 Mar;72(3):383-92. doi: 10.1111/j.1365-2265.2009.03679.x. Epub 2009 Aug 4. Review.

PMID:
19681917
9.

Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.

Alvarez-Blasco F, Martínez-García MA, Luque-Ramírez M, Parraza N, San Millán JL, Escobar-Morreale HF.

PLoS One. 2009;4(5):e5606. doi: 10.1371/journal.pone.0005606. Epub 2009 May 19.

10.

Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism.

Martínez-García MA, Luque-Ramírez M, San-Millán JL, Escobar-Morreale HF.

Diabetes Care. 2009 Aug;32(8):1525-30. doi: 10.2337/dc09-0420. Epub 2009 Apr 28.

11.

Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome.

Escobar-Morreale HF, Luque-Ramírez M, San-Millán JL.

Diabetes Care. 2009 Jan;32(1):e6. doi: 10.2337/dc08-1690. No abstract available.

PMID:
19114623
12.

Unified criteria for ultrasonographic diagnosis of ADPKD.

Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D.

J Am Soc Nephrol. 2009 Jan;20(1):205-12. doi: 10.1681/ASN.2008050507. Epub 2008 Oct 22.

13.

Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome.

Escobar-Morreale HF, Botella-Carretero JI, Martínez-García MA, Luque-Ramírez M, Alvarez-Blasco F, San Millán JL.

Eur J Endocrinol. 2008 Sep;159(3):225-32. doi: 10.1530/EJE-08-0107. Epub 2008 Jun 25.

PMID:
18579554
14.

The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery.

Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, Peromingo R, San Millán JL, Escobar-Morreale HF.

Obes Surg. 2008 Aug;18(8):1000-6. doi: 10.1007/s11695-007-9369-7. Epub 2008 Mar 19.

PMID:
18350343
15.

Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome.

Escobar-Morreale HF, Insenser M, Cortón M, San Millán JL, Peral B.

Proteomics Clin Appl. 2008 Mar;2(3):444-55. doi: 10.1002/prca.200780031.

PMID:
21136846
16.

Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.

Cortón M, Botella-Carretero JI, López JA, Camafeita E, San Millán JL, Escobar-Morreale HF, Peral B.

Hum Reprod. 2008 Mar;23(3):651-61. Epub 2007 Dec 22.

PMID:
18156650
17.

The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event.

Botella-Carretero JI, Alvarez-Blasco F, Martinez-García MA, Luque-Ramírez M, San Millán JL, Escobar-Morreale HF.

Obes Surg. 2007 Sep;17(9):1199-208.

PMID:
18074495
18.

A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

Escobar-Morreale HF, Sanchón R, San Millán JL.

J Clin Endocrinol Metab. 2008 Feb;93(2):527-33. Epub 2007 Nov 13.

PMID:
18000084
19.

Abdominal adiposity and the polycystic ovary syndrome.

Escobar-Morreale HF, San Millán JL.

Trends Endocrinol Metab. 2007 Sep;18(7):266-72. Epub 2007 Aug 10. Review.

PMID:
17693095
20.

Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF.

Diabetes Care. 2007 Sep;30(9):2309-13. Epub 2007 May 29.

PMID:
17536071
21.

Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women.

Botella-Carretero JI, Alvarez-Blasco F, San Millán JL, Escobar-Morreale HF.

Eur J Endocrinol. 2007 May;156(5):539-45.

PMID:
17468189
22.

Analysis of published PKD1 gene sequence variants.

Gout AM; ADPKD Gene Variant Consortium, Ravine D, Harris PC, Rossetti S, Peters D, Breuning M, Henske EP, Koizumi A, Inoue S, Shimizu Y, Thongnoppakhun W, Yenchitsomanus PT, Deltas C, Sandford R, Torra R, Turco AE, Jeffery S, Fontes M, Somlo S, Furu LM, Smulders YM, Mercier B, Ferec C, Burtey S, Pei Y, Kalaydjieva L, Bogdanova N, McCluskey M, Geon LJ, Wouters CH, Reiterova J, Stekrová J, San Millan JL, Aguiari G, Del Senno L.

Nat Genet. 2007 Apr;39(4):427-8. Review. No abstract available.

PMID:
17392796
23.

Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome.

Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, San Millán JL, Escobar-Morreale HF.

Diabetes Care. 2006 Nov;29(11):2556. No abstract available.

PMID:
17065702
24.

Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, Escobar-Morreale HF, Peral B.

J Clin Endocrinol Metab. 2007 Jan;92(1):328-37. Epub 2006 Oct 24.

25.

Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.

Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF.

Arch Intern Med. 2006 Oct 23;166(19):2081-6.

PMID:
17060537
26.

The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.

San Millán JL, Alvarez-Blasco F, Luque-Ramírez M, Botella-Carretero JI, Escobar-Morreale HF.

Hum Reprod. 2006 Dec;21(12):3157-61. Epub 2006 Jul 31.

PMID:
16880229
27.

The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance.

Villuendas G, Botella-Carretero JI, López-Bermejo A, Gubern C, Ricart W, Fernández-Real JM, San Millán JL, Escobar-Morreale HF.

Eur J Endocrinol. 2006 Aug;155(2):331-6.

PMID:
16868148
28.

Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.

Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, Richart C, Fernández-Real JM.

Clin Endocrinol (Oxf). 2006 Jul;65(1):88-91.

PMID:
16817825
29.

Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.

Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchón R, Luque-Ramírez M, San Millán JL.

Hum Reprod. 2006 Sep;21(9):2257-65. Epub 2006 May 4.

PMID:
16675483
30.

Genomic variants in polycystic ovary syndrome.

Luque-Ramírez M, San Millán JL, Escobar-Morreale HF.

Clin Chim Acta. 2006 Apr;366(1-2):14-26. Epub 2005 Dec 7. Review.

PMID:
16337616
31.

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery.

Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millán JL.

J Clin Endocrinol Metab. 2005 Dec;90(12):6364-9. Epub 2005 Sep 27.

PMID:
16189250
32.

Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.

Escobar-Morreale HF, Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sancho J, San Millán JL.

Diabetes Care. 2005 Aug;28(8):2042-4. No abstract available.

PMID:
16043756
33.
34.

A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.

San Millán JL, Botella-Carretero JI, Alvarez-Blasco F, Luque-Ramírez M, Sancho J, Moghetti P, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2005 Jul;90(7):4157-62. Epub 2005 Apr 12.

PMID:
15827106
35.

The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

Escobar-Morreale HF, Luque-Ramírez M, San Millán JL.

Endocr Rev. 2005 Apr;26(2):251-82. Epub 2004 Nov 23. Review.

PMID:
15561799
36.

Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.

San Millán JL, Cortón M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2004 Jun;89(6):2640-6.

37.

Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.

Roldán B, San Millán JL, Escobar-Morreale HF.

Am J Pharmacogenomics. 2004;4(2):93-107. Review.

PMID:
15059032
38.

Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.

Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millán JL.

J Clin Endocrinol Metab. 2004 Feb;89(2):806-11.

PMID:
14764799
39.

Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide.

Cortón M, Villuendas G, Botella JI, San Millán JL, Escobar-Morreale HF, Peral B.

Proteomics. 2004 Feb;4(2):438-41.

PMID:
14760714
40.

Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism.

Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J, San Millán JL.

Obes Res. 2003 Aug;11(8):987-96.

41.

Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.

Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Millán JL.

Diabetologia. 2003 May;46(5):625-33. Epub 2003 May 9.

PMID:
12739017
42.

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y.

J Am Soc Nephrol. 2003 May;14(5):1164-74.

43.

Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome.

Villuendas G, Escobar-Morreale HF, Tosi F, Sancho J, Moghetti P, San Millán JL.

Fertil Steril. 2003 Jan;79(1):219-20. No abstract available.

PMID:
12524094
44.

Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.

Peral B, San Millán JL, Castello R, Moghetti P, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2002 Aug;87(8):3977-83.

45.

The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC.

J Am Soc Nephrol. 2002 May;13(5):1230-7.

46.

Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women.

Calvo RM, Tellería D, Sancho J, San Millán JL, Escobar-Morreale HF.

Fertil Steril. 2002 Apr;77(4):666-8.

PMID:
11937112
47.

The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism.

Villuendas G, San Millán JL, Sancho J, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2002 Mar;87(3):1134-41.

PMID:
11889177
48.

Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism.

Escobar-Morreale HF, Peral B, Villuendas G, Calvo RM, Sancho J, San Millán JL.

Fertil Steril. 2002 Mar;77(3):581-7.

PMID:
11872216
49.
50.

Differential developmental regulation and functional effects on pre-TCR surface expression of human pTalpha(a) and pTalpha(b) spliced isoforms.

Ramiro AR, Navarro MN, Carreira A, Carrasco YR, de Yébenes VG, Carrillo G, San Millán JL, Rubin B, Toribio ML.

J Immunol. 2001 Nov 1;167(9):5106-14.

Supplemental Content

Loading ...
Support Center